Skip to main content

FDA recall, , Moderate risk

Siemens ARTIS Icono Biplane, Ceiling and Floor

Potential for loss of movement capability after adjusting the detector lift height to its maximum or minimum limits.

What happened

Siemens Medical Solutions USA, Inc., of Malvern, Pennsylvania, began a recall on May 20, 2026, for ARTIS icono floor, ARTIS icono biplane, and ARTIS icono ceiling due to a potential for loss of movement capability after adjusting the detector lift height to its maximum or minimum limits. The recall was added to the FDA's Enforcement Report and classified on July 1, 2026, and was in the FDA's weekly enforcement report on July 8, 2026. Distribution was US Nationwide.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

3 models

Affected if its model number is listed.

  1. ARTIS icono biplane.

    Model
    • 11327600
  2. ARTIS icono ceiling.

    Model
    • 11328100
  3. ARTIS icono floor.

    Model
    • 11327700

Recall details

Company began the recall
Sold in

US Nationwide distribution.

Company
Siemens Medical Solutions USA, IncMalvern, Pennsylvania
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99079
Recall numbers
Z-2641-2026 to Z-2643-2026

All recalls from Siemens Medical Solutions USA, Inc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)